Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Microbix J (MBX.TO)

Microbix J (MBX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 42,378
  • Shares Outstanding, K 136,705
  • Annual Sales, $ 16,515 K
  • Annual Income, $ -39 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.71
  • Price/Sales 1.82
  • Price/Cash Flow 20.05
  • Price/Book 1.51
  • Price/Earnings ttm 8.44
  • Earnings Per Share ttm 0.04
  • Most Recent Earnings $0.00 on 08/14/24
  • Next Earnings Date 12/19/24
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend 0.275 on 09/02/99
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.01
  • Growth Rate Est. (year over year) +9,990,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3000 +5.00%
on 10/30/24
0.3400 -7.35%
on 10/23/24
-0.0200 (-5.97%)
since 10/11/24
3-Month
0.3000 +5.00%
on 10/30/24
0.3850 -18.18%
on 08/27/24
-0.0300 (-8.70%)
since 08/14/24
52-Week
0.2400 +31.25%
on 11/15/23
0.4500 -30.00%
on 02/14/24
+0.0650 (+26.00%)
since 11/14/23

Most Recent Stories

More News
Stocks in play: Microbix Biosystems Inc.

Announces that key opinion leader collaborators are presenting results of a Microbix Quality Assessment ...

MBX.TO : 0.3150 (+1.61%)
KOL Collaborators Present Microbix HPV Test-Control Results

MBX.TO : 0.3150 (+1.61%)
MBXBF : 0.2195 (-2.53%)
Stocks in play: Microbix Biosystems Inc.

Is presenting results of a novel Quality Assessment Product for supporting patient diagnosis and tissue ...

MBX.TO : 0.3150 (+1.61%)
Microbix Presents Novel HSV Test Control at EMMD

MBX.TO : 0.3150 (+1.61%)
MBXBF : 0.2195 (-2.53%)
Stocks in play: Microbix Biosystems Inc.

Announces that it has upgraded its European Union regulatory compliance for its diagnostic assay quality ...

MBX.TO : 0.3150 (+1.61%)
Microbix Achieves Essential EU Regulatory Accreditations

MBX.TO : 0.3150 (+1.61%)
MBXBF : 0.2195 (-2.53%)
Stocks in play: Microbix Biosystems Inc.

Announces its hosting of Associate Minister of Small Business of Ontario, the Honourable Nina Tangri, ...

MBX.TO : 0.3150 (+1.61%)
Stocks in play: Microbix Biosystems Inc.

Reports results for its second quarter and first half of fiscal 2024 ended March 31. Q2 revenue was ...

MBX.TO : 0.3150 (+1.61%)
Stocks in play: Microbix Biosystems Inc.

Is presenting results of its use of Microbix Quality Assessment Products for accreditation of clinical ...

MBX.TO : 0.3150 (+1.61%)
Stocks in play: Microbix Biosystems Inc.

Will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference taking place ...

MBX.TO : 0.3150 (+1.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and...

See More

Key Turning Points

3rd Resistance Point 0.3233
2nd Resistance Point 0.3217
1st Resistance Point 0.3183
Last Price 0.3150
1st Support Level 0.3133
2nd Support Level 0.3117
3rd Support Level 0.3083

See More

52-Week High 0.4500
Fibonacci 61.8% 0.3698
Fibonacci 50% 0.3450
Fibonacci 38.2% 0.3202
Last Price 0.3150
52-Week Low 0.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar